Casect Launches AI-Enhanced Case Log Platform for Surgeons 
4D Molecular Therapeutics to Participate in BofA Securities 2021 Virtual Health Care Conference
EMERYVILLE, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT), a clinical-stage gene therapy company harnessing the...
Kraig Biocraft Laboratories Celebrates Arbor Day by Funding Planting of more than 100,000 Mulberry Trees
Kraig Labs honors its commitment to eco-responsible Spider Silk production with significant expansion of tree plantingANN ARBOR, Mich., April 30,...
Calithera Biosciences to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021
SOUTH SAN FRANCISCO, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused...
IRADIMED CORPORATION Announces First Quarter 2021 Financial Results
Reports first quarter 2021 revenue of $9.2 million, GAAP diluted EPS of $0.11 and non-GAAP diluted EPS of $0.13Reports combined...
Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled interferon beta in COVID-19 patients and encouraging combined data for whole SG016 trial
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled...
Clene Nanomedicine Receives Two Patent Notice of Allowances in the U.S. for Its Platform Nanocrystal Therapeutic Technology
IP portfolio now totals over 160 patents issued, allowed, and pendingSALT LAKE CITY, April 30, 2021 (GLOBE NEWSWIRE) -- Clene...
Pfizer and BioNTech Submit Request to Expand Conditional Marketing Authorization of COMIRNATY® in the EU to Adolescents
NEW YORK and MAINZ, GERMANY, April 30, 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX)...
BeyondSpring Announces Fourth Quarter and Year End 2020 Financial Results and Provides a Corporate Update
- NDAs filed in the U.S. and China in Mar. 2021 based on superior data from Phase 3 PROTECTIVE-2 trial...
Tessa Therapeutics Announces Enrollment of 12 Patient Pilot Cohort in its Relapsed or Refractory Hodgkin Lymphoma Phase 2 Study
82 Patient Pivotal cohort expected to commence in second half of 2021 BEDMINSTER, N.J. and SINGAPORE, April 30, 2021 (GLOBE...
Vistin Pharma ASA : Key information relating to the cash dividend to be paid by Vistin Pharma ASA
Dividend amount: NOK 0.5 Declared currency: NOK Last day including right: 20 May 2021 Ex-date: 21 May 2021 Record date:...
Illingworth Research Group Recognized with Queen’s Award for Enterprise: International Trade 2021
MORRISVILLE, N.C., April 30, 2021 (GLOBE NEWSWIRE) -- The Illingworth Research Group, a Syneos Health® company, has been recognized with...
PCI Biotech: Invitation to first quarter 2021 results presentation
Oslo, Norway, 30 April 2021 - PCI Biotech’s (OSE: PCIB) first quarter 2021 interim report will be released on 7...
Audited annual report 2020
New JSC Olainfarm strategy is approvedThe Company reviewed operations in the main marketsJSC Olainfarm continued investments to modernize its operations...
Conscience Project challenges Ontario College of Physicians policy
Policy that would force physicians out of Covid fight not in public interestPOWELL RIVER, British Columbia, April 30, 2021 (GLOBE...
Biophytis – Second Combined General Meeting to Take Place on May 10, 2021 without the physical presence of its shareholders
PARIS and CAMBRIDGE, Mass., April 30, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company...
Change in numbers of shares and votes in Saniona AB (publ)
PRESS RELEASE April 30, 2021 During April, the registered number of shares and votes in Saniona AB (publ) (“Saniona”) has...
Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled interferon beta in COVID-19 patients and encouraging combined data for whole SG016 trial
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled...
Glycotope Announces Poster Presentations at the 2021 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting
Glycotope Announces Poster Presentations at the 2021 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting Berlin, Germany, April 30,...
Nicox Updates on Fera Pharmaceuticals’ Continuing Evaluation of Naproxcinod
Press ReleaseNicox Updates on Fera Pharmaceuticals’ Continuing Evaluation of NaproxcinodApril 30, 2021 – release at 7:30 am CET Sophia Antipolis,...
OXURION NV Presenting Scientific Data at ARVO 2021 Annual Meeting
Leuven, BE, Boston, MA, US – April 30st, 2021 – 7.30 AM CET – Oxurion NV (Euronext Brussels: OXUR) is...